STAT3-IN-15 is a potent and orally active STAT3 inhibitor against idiopathic pulmonary fibrosis (IPF). STAT3-IN-15 inhibits STAT3 phosphorylation. STAT3-IN-15 also inhibits the migration and deformation of epithelial cells induced by TGF-beta1 and inhibit epithelial-mesenchymal transition (EMT)[1].
Molekulargewicht:
422.42
Reinheit:
98.99
Formel:
C20H17F3N2O3S
Target-Kategorie:
STAT
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten